Regeneron Pharmaceuticals Overview
Regeneron Pharmaceuticals Target Price
Analysts' 12-month price predictions for REGN.
Get informed when a big investor buys or sells
+ FollowShare Price
$654.27
Average Target Price
$831.47
27.1% upside
27.1% upside17 analysts in the last 4 months
High: $995 | Low: $641
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-19 | Canaccord GenuityJohn Newman | $875 | 33.7% upside |  |
| 2026-05-18 | BMO Capital | $730 | 11.6% upside | |
| 2026-05-18 | RBC Capital | $707 | 8.1% upside | |
| 2026-05-18 | Evercore ISI | $825 | 26.1% upside | |
| 2026-05-18 | Piper Sandler | $855 | 30.7% upside | |
| 2026-05-18 | Wolfe ResearchAlexandria Hammond | $860 | 31.4% upside | |
| 2026-05-18 | Truist Financial | $778 | 18.9% upside | |
| 2026-05-18 | Leerink PartnersMarket Perform | $641 |  2% downside | |
| 2026-05-01 | GuggenheimYatin Suneja | $995 | 52.1% upside | |
| 2026-04-30 | Morgan StanleyTerence Flynn | $788 | 20.4% upside | |
| 2026-04-30 | Barclays | $917 | 40.2% upside | |
| 2026-04-30 | Truist Financial | $796 | 21.7% upside | |
| 2026-04-22 | Raymond JamesChris Raymond | $910 | 39.1% upside | |
| 2026-04-10 | Morgan Stanley | $796 | 21.7% upside | |
| 2026-04-08 | Bernstein | $921 | 40.8% upside | |
| 2026-03-09 | Truist FinancialGreg Renza | $818 | 25% upside | |
| 2026-03-06 | BarclaysEliana Merle | $923 | 41.1% upside | |
| 2026-03-02 | RBC CapitalBrian Abrahams | $765 | 16.9% upside | |
| 2026-02-09 | Guggenheim | $975 | 49% upside | |
| 2026-02-02 | Cantor FitzgeraldCarter Gould | $800 | 22.3% upside | |
| 2026-02-02 | Tudor PickeringWilliam Pickering | $925 | 41.4% upside | |
| 2026-02-02 | Oppenheimer | $865 | 32.2% upside | |
| 2026-02-02 | Robert W. BairdBrian Skorney | $742 | 13.4% upside | |
| 2026-02-01 | Morgan StanleyTerence Flynn | $769 | 17.5% upside | |
| 2026-01-30 | Raymond James | $870 | 33% upside | |
| 2026-01-27 | Tudor PickeringWilliam Pickering | $916 | 40% upside | |
| 2026-01-27 | Bernstein | $916 | 40% upside | |
| 2026-01-27 | RBC CapitalBrian Abrahams | $745 | 13.9% upside | |
| 2026-01-22 | Evercore ISI | $875 | 33.7% upside | |
| 2026-01-08 | Goldman Sachs | $914 | 39.7% upside | |
| 2025-12-17 | Leerink PartnersAndrew Berens | $873 | 33.4% upside | |
| 2025-12-12 | Morgan StanleyTerence Flynn | $768 | 17.4% upside | |
| 2025-12-10 | HSBC | $985 | 50.5% upside | |
| 2025-12-04 | Canaccord Genuity | $1,057 | 61.6% upside | |
| 2025-12-04 | BMO CapitalEvan Seigerman | $850 | 29.9% upside | |
| 2025-11-24 | Truist Financial | $798 | 22% upside | |
| 2025-11-24 | HSBC | $890 | 36% upside | |
| 2025-11-24 | Scotiabank | $770 | 17.7% upside | |
| 2025-11-20 | Wells FargoMohit Bansal | $700 | 7% upside | |
| 2025-10-29 | RBC Capital | $708 | 8.2% upside | |
| 2025-10-29 | Guggenheim | $865 | 32.2% upside | |
| 2025-10-29 | Bernstein | $818 | 25% upside | |
| 2025-10-29 | Robert W. Baird | $637 | 2.6% downside | |
| 2025-10-29 | Wells Fargo | $615 | 6% downside | |
| 2025-10-29 | BMO CapitalEvan Seigerman | $725 | 10.8% upside | |
| 2025-10-29 | Robert W. BairdBrian Skorney | $630 | 3.7% downside | |
| 2025-10-29 | Cantor FitzgeraldCarter Gould | $740 | 13.1% upside | |
| 2025-10-28 | Morgan Stanley | $767 | 17.2% upside | |
| 2025-10-28 | Raymond JamesChristopher Raymond | $723 | 10.5% upside | |
| 2025-10-10 | Morgan Stanley | $756 | 15.5% upside | |